You’ve invested countless hours and resources into developing your breakthrough drug. Ensuring its long-term stability is critical, yet traditional Type I vials made from multicomponent glass can put this stability at risk. They may be prone to reacting with their contents over time, which can alter drug formulations and reduce shelf life. Drug developers using Type I vials have had no choice but to tolerate such interactions — until now.